significantly more short and long term complications and had worse sexual function over time (functional data not shown).
INTRODUCTION AND OBJECTIVES:
It is recognised inadequate training in robotic surgery results in increased complications and costs. Standardising modular training with defined steps and the errors to avoid will enable proficiency-based progression (PBP) training. We aimed to achieve consensus amongst experts on the key steps of RARP and the associated errors and critical errors (CE) related to those steps.
METHODS: The project was carried out in phases: a systematic review of current evidence, 5 experts to review videos of expert and trainee surgeons to define the metrics. A panel of 18 experts then validated the key metrics with a modified Delphi process. Consensus opinion was defined as !80% agreement. We compared changes in the number of metric units before and after the Delphi meeting for statistical significance with Wilcoxon Signed Rank Tests. The relationship between the number of metric units before and after was assessed with Pearson's Product Moment Correlation Coefficient.
RESULTS: Experts came from 11 European countries. 15 out of 18 (83%) were fellowship trained, median no. of RARP cases performed 1500. CONCLUSIONS: Using a modified Delphi process we achieved international consensus among European experts for a PBP approach to RARP training within a short time frame. We have described a standardised definition of optimised surgical technique in RARP and the errors to avoid. These metrics lay the foundation for developing PBP training in RARP.
Source of Funding: None

PD45-09 THE PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES OF DECREASING TO PATHOLOGIC GLEASON SCORE 6-7 AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH BIOPSY GLEASON SCORE 8-10
RESULTS: In a total of 860 patients, pathological findings showed that bGS8, bGS!9 were present in 623 cases (72.4%), 237 cases (27.6%), respectively. 332 patients were downgraded to pGS 6-7 after RP. In these 332 patients, and bGS8, bGS!9 were present in 284 cases (85.5%), 48 cases (14.5%), respectively. PSA, clinical stage on mpMRI, pathologic adverse features such as extracapsular extension, seminal vesicle invasion (SVI), positive surgical margin(PSM) were significant statistical difference between Downgrade group and No_downgrade group. In the univariate and multivariate logistic regression analyses, bGS!9, PSA !10 ng/ml and above clinical T3b on multiparametric Magnetic Resonance Imaging (mpMRI) was a significant predictor of pGS downgrade (OR 0.349, p<0.001 , OR 0.634, p[0.004, OR 0.400, p<0.001). Also, pGS Downgrade was a significant positive predictor of BCR following RP in patients with high bGS (pGS8: HR 1.699, p <0.001. pGS!9: HR 1.765, p<0.001). SVI, PSM were also statistically related to BCR (p <0.001).
CONCLUSIONS: In patients with high bGS, bGS8, PSA <10 ng/ ml and without seminal vesicle invasion on mpMRI may show a downgrade in pGS. These patients may have few adverse pathologic features and show a good prognosis, so active treatment is needed.
Source of Funding: none
PD45-10 IMPACT OF CLINICAL TUMOR STAGE AND PREOPERATIVE PSA-VALUE ON CANCER SPECIFIC SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH GLEASON 9-10 ON PROSTATE BIOPSY
INTRODUCTION AND OBJECTIVES: According to the d'Amico classification, high-risk prostate cancer (PCa)disease is defined as either preoperative PSA>20ng/ml, clinical tumor stage (cT) !T2c or biopsy Gleason score(bGS) 8-10.The International Society of Urological Pathology (ISUP) has further stratified this high risk population in 2 subgroups depending whether they have bGS8 (Grade group 4) or 9-10 (Grade group 5). This study aims at investigating the impact of preoperative PSA and cT-stage in patients with very-high-risk bGS 9-10 (Grade group 5) PCa on cancer-specific survival (CSS) and overall survival (OS).
METHODS: From the multicenter EMPaCT database, which contains detailed clinico-pathological and cancer outcome data of highrisk PCa patients treated with radical prostatectomy, we selected all patients with bGS9-10. In this subgroup, we investigated the impact of bGS (9 vs. 10), preoperative PSA ( 20ng/ml vs.>20ng/ml) and clinical T-stage ( cT2c vs. T3a vs. T3b-4) on CSS and OS. Furthermore, the possible interaction of supplementary risk factors on CSS and OS in patients with bGS 9-10 were studies by subdividing patients into 6 subgroups: cT2cþ 20ng/ml, T3aþ 20ng/ml, T3b-4þ 20ng/ml, cT2cþ>20ng/ml, T3aþ>20ng/ml and T3b-4þ>20ng/ ml. We used Kaplan-Meier analysis with log rank tests to compare subgroups.
RESULTS: A total of 1370 patients were included in the analysis of whom 487(35.5%) and 537(39.2%) had data on CSS and OS available respectively. Of all patients, 1233 (90%) had biopsy Gleason score 9 and 137 (10%) biopsy score 10. Most patients had a PSAvalue 20ng/ml (74.3%) and cT-stage cT2c(79.4%). We did not observe a significant impact of preoperative PSA independent of cTstage (and vice-versa) on CSS and OS. Nor did we find significant differences in CSS or OS between the 6 subgroups (p [0.9 and p[0.99, respectively) . Patients with bGS 9 had a trend towards better CSS vs.those with bGS10 (Mean CSS 145 vs. 96 mo., p[0.06).
CONCLUSIONS: In PCa patients with bGS 9-10, additional preoperative high-risk factors (PSA>20ng/ml and cT3b-4) had no measurable impact on CSS and OS. Therefore, bGS9-10 on itself appeared to be the single-most important presurgical predictor of OS and CSS.
